Schedule 13G ownership disclosure
AtriCure Inc
Common Stock · CUSIP: 04963C209
Event date: 2024-09-30
- Filing-level shares
- 2,790,758.00
- Percent of class
- 5.7%
- Champlain Investment Partners, LLC
Shares: 2,790,758.00 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001315478-24-000036
- Form type
- SCHEDULE 13G
- Filer
- AtriCure, Inc.
- CIK
- CIK 1323885
- Filed
- Nov 12, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership